Pancreatic Cancer Research

ResearcherUniversity of MilanNo recent work listed

Ersilia Lucenteforte

Matched on ORCID iD 0000-0001-5608-5902; OpenAlex author ID A5021233300. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2011: 3 papers · 2012: 3 papers · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper

Papers 10

  1. Dietary acrylamide and the risk of pancreatic cancer in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdw618↗
  2. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
  3. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/aje/kwt052↗
  4. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). First author DOI 10.1093/annonc/mdt336↗
  5. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdr120↗
  6. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). First author DOI 10.1093/annonc/mdr541↗
  7. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). First author DOI 10.1093/annonc/mds140↗
  8. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdq613↗
  9. Reply to Are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Co-author DOI 10.1093/annonc/mdr305↗
  10. Reproductive and hormonal factors and pancreatic cancer risk in women. Co-author DOI 10.1097/mpa.0b013e31820bf986↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carlo La Vecchia · 10 shared papers, 2011–2017 · strength 0.26
  2. Elizabeth T. H. Fontham · 9 shared papers, 2011–2017 · strength 0.23
  3. Eric J. Duell · 9 shared papers, 2011–2017 · strength 0.23
  4. Paige M. Bracci · 9 shared papers, 2011–2017 · strength 0.23
  5. Cristina Bosetti · 8 shared papers, 2011–2017 · strength 0.21
  6. Jerry Polesel · 8 shared papers, 2011–2017 · strength 0.21
  7. Paolo Boffetta · 8 shared papers, 2011–2017 · strength 0.21
  8. Dali Li · 7 shared papers, 2011–2017 · strength 0.18
  9. H. Bas Bueno-de-Mesquita · 8 shared papers, 2011–2014 · strength 0.18
  10. Patrick Maisonneuve · 8 shared papers, 2011–2014 · strength 0.18
  11. Steve Gallinger · 8 shared papers, 2011–2014 · strength 0.18
  12. Moustapha Hassan · 6 shared papers, 2011–2017 · strength 0.16
  13. Sara H. Olson · 7 shared papers, 2011–2014 · strength 0.16
  14. Robert C. Kurtz · 7 shared papers, 2011–2014 · strength 0.16
  15. Eva Negri · 7 shared papers, 2011–2014 · strength 0.16
  16. Michelle Cotterchio · 7 shared papers, 2011–2014 · strength 0.15
  17. Renato Talamini · 7 shared papers, 2011–2013 · strength 0.15
  18. Parviz Ghadirian · 7 shared papers, 2011–2014 · strength 0.15
  19. Debra T. Silverman · 7 shared papers, 2011–2014 · strength 0.15
  20. Gloria M. Petersen · 7 shared papers, 2011–2014 · strength 0.15
  21. Rachel Ε. Neale · 3 shared papers, 2013–2017 · strength 0.11
  22. Kristin E. Anderson · 3 shared papers, 2013–2017 · strength 0.11
  23. Herbert Yu · 5 shared papers, 2011–2013 · strength 0.10
  24. Harvey A. Risch · 5 shared papers, 2011–2013 · strength 0.10
  25. Valentina Rosato · 2 shared papers, 2014–2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.